Skip to content

Organic Pollutant Build-Up in Body Fat and Stomach Tissue Linked to Obesity Levels

Accumulation Profiles of Specific Organic Pollutants in Adipose and Gastric Tissues of Bariatric Surgery Patients and Their Clinical Correlations With Obesity Severity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07126743
Enrollment
100
Registered
2025-08-17
Start date
2025-08-01
Completion date
2026-08-01
Last updated
2025-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity &Amp; Overweight

Keywords

Metabolic syndrome, Organic pollutants, Obesity

Brief summary

This study looks at whether certain environmental chemicals, called organic pollutants, build up in the body fat and stomach tissues of people with obesity who are having weight-loss (bariatric) surgery. These pollutants can come from things like plastics, pesticides, or industrial waste, and may affect health in different ways. The investigators will measure the amount of these pollutants in tissue samples taken during surgery and see if the levels are different in people with mild, moderate, or severe obesity. By understanding these patterns, the investigators hope to learn more about how environmental factors may influence obesity and related health problems. The findings could help guide future prevention and treatment strategies for patients.

Detailed description

Obesity is a complex health condition influenced by both lifestyle and environmental factors. Among these factors, persistent organic pollutants (POPs) - such as certain plastic-related chemicals, pesticides, and industrial byproducts - have raised growing concern due to their ability to accumulate in human tissues over time and potentially interfere with metabolism. This study focuses on patients with obesity who are undergoing bariatric surgery. During surgery, the investigators will collect small samples of adipose (fat) tissue and gastric tissue under sterile conditions. These samples will be analyzed for the presence and concentration of specific organic pollutants using validated laboratory methods. The investigators will compare pollutant accumulation patterns across patients with varying levels of obesity severity, aiming to identify possible associations between pollutant burden and obesity-related clinical characteristics. The results are expected to provide new insights into the environmental contributions to obesity, beyond diet and physical activity. By clarifying how pollutant accumulation in different tissues relates to obesity severity, the findings could help inform prevention strategies, refine clinical management, and highlight the need for targeted public health policies addressing environmental exposures.

Interventions

OTHERexposure to organic pollutant

Small samples of subcutaneous and visceral adipose tissue will be analyzed for the presence and concentration of specific organic pollutants using validated analytical chemistry methods, such as gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS).

Sponsors

Dong Peng
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults ≥18 years. * BMI ≥30 kg/m² at screening (measured within 30 days before surgery). * Scheduled for primary bariatric surgery (e.g., sleeve gastrectomy or Roux-en-Y gastric bypass) for clinical indications. * Able to provide informed consent. * Willing to allow intraoperative collection of subcutaneous/visceral adipose tissue and gastric tissue for pollutant analysis. * Availability of basic preoperative clinical data (demographics, comorbidities, relevant labs).

Exclusion criteria

* Prior bariatric or major upper gastrointestinal surgery that alters stomach/anatomy relevant to sampling. * Pregnant or breastfeeding at screening or on day of surgery. * Active malignancy (excluding non-melanoma skin cancers) or ongoing systemic immunosuppressive therapy (e.g., chronic corticosteroids, biologics) within 3 months. * Severe organ dysfunction: decompensated cirrhosis (Child-Pugh C) or eGFR \<30 mL/min/1.73m². * Acute infection or decompensated chronic illness that would preclude elective surgery per treating team. * Documented high-level occupational or accidental chemical exposure within 6 months (e.g., pesticide poisoning) likely to bias tissue pollutant measurements. * Participation in another interventional study expected to affect weight or metabolism within 3 months. * Inadequate tissue obtainable at surgery for analysis (determined intraoperatively by the investigators).

Design outcomes

Primary

MeasureTime frameDescription
Obesity SeverityAt baseline (within 1 month before bariatric surgery).The investigators will assess obesity severity based on body mass index (BMI), calculated as body weight in kilograms divided by height in meters squared (kg/m²). BMI will be obtained using standardized measurements of height and weight during the preoperative evaluation. Obesity severity will be categorized according to World Health Organization (WHO) criteria (Class I: 30.0-34.9 kg/m², Class II: 35.0-39.9 kg/m², Class III: ≥ 40.0 kg/m²).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026